AMGN
AmgenDNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Operating peers and competitors
Source-backed product markets and frozen research comparisons. Valuation comparators remain in the existing peer table.
Loading market evidence...
Research comparisons do not establish forecast usefulness or trading returns.
Compare shared product markets
Membership only; no portfolio weights or estimated losses.
+
Peers tracked
11
U.S. public peers
Grade Position
Below peers
vs peer average
AMGN vs peer average
19/100
AMGN vs. peer average (D vs. B)
Grade spread
A 3 · B 6 · C 1 · F 1
Graded peers loaded
Coverage
11 graded
100% of tracked
Peer overview
ABBV is the first available peer comparator.
Major biologics and immunology franchise; comparable revenue stability and patent-timing risk.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
AMGN
Amgen
ABBV
AbbVie
Grade
D
C
Momentum
93
92
Value
61
60
Sentiment
27
33
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Mixed
Grade position vs ABBV
AMGN / ABBV
Grade Position
Below peers
AMGN vs. peer average (D vs. B)
19/100
Momentum
93
AMGNValue
61
AMGNSentiment
27
ABBVRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs AMGN
ABBV is the first peer returned for this comparison set.